# Baxter Healthcare Corporation – FDA Inspection, Nov 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/c9feb4e5-d47a-4f96-b8b4-93ff0d859b9d
Source feed: FDA_Inspections

> FDA inspection 1072203 of Baxter Healthcare Corporation, November 20, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1072203
- Company Name: Baxter Healthcare Corporation
- Inspection Date: 2018-11-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1284446 - 2025-09-29](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/bca90a34-d045-41e0-8c4a-1c7913aa79df)
- FDA Inspection 1210861 - 2023-07-14
- FDA Inspection 1010362 - 2017-03-29
- FDA Inspection 983354 - 2016-04-27
- FDA Inspection 920235 - 2015-03-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/francis-a-guidry/fd6d2a17-7f94-4f7c-8284-ad1f07d703e9)

Company: https://www.keypedia.com/companies/baxter-healthcare-corporation/738590ab-c241-4de1-aaec-722e154bfc45

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c